O’FALLON, Mo., Feb. 27 /PRNewswire-FirstCall/ -- Synergetics USA, Inc. announced today plans to release results for its fiscal second quarter ended January 30, 2007 on Thursday, March 8, 2007, after market close. In conjunction with the release, management will host a conference call the morning of Friday, March 9, 2007 at 9:30 a.m. Eastern Time.
During the call, Gregg D. Scheller, Synergetics’ president and chief executive officer, and Pamela G. Boone, executive vice president and chief financial officer, will provide an overview of the second quarter financial performance and business highlights.
The toll free dial-in number to listen and participate live on this call is (888) 787-0677, confirmation code 1325498. For callers outside the U.S., the number is (706) 679-4689. An audiotape replay will be available approximately two hours following the conclusion of the call through Monday, March 26, 2007 and can be accessed by dialing toll free (800) 642-1687, confirmation code 1325498. Callers outside the U.S. can access this recording at (706) 645-9291. Information regarding replay of the call will also be available at http://www.synergeticsusa.com.
About Synergetics USA, Inc.
Synergetics USA, Inc. resulted from the September 2005 combination of Valley Forge Scientific Corp. and Synergetics, Inc., bringing together their respective unique capabilities in bipolar electrosurgical generators and design, and manufacture of microsurgical hand instruments. Synergetics USA, Inc. designs, manufactures and markets medical devices for use primarily in ophthalmic surgery and neurosurgery and for other healthcare applications. Its products are designed and manufactured to support micro or minimally invasive surgical procedures. In addition to its surgical devices and equipment, it designs and manufactures disposable and non-disposable supplies and accessories for use with such devices and equipment. It also manufactures and sells bipolar electrosurgical generators and other generators, based on its DualWave(TM) technology, and complementary instrumentation and disposable products for use in neurosurgery, spine surgery, pain control and in dental applications. Synergetics sells its products primarily to hospitals, clinics and surgeons in approximately 70 countries.
Forward-Looking Statements
Some statements in this release may be “forward-looking statements” for the purposes of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified by words such as “believe,” “expect,” “anticipate,” “plan,” “potential,” “continue” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important facts that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These facts, risks and uncertainties are discussed in our Annual Report on Form 10-K for the year ended July 31, 2006, as updated from time to time in our filings with the Securities and Exchange Commission.
SYNERGETICS USA, INC. 3845 Corporate Centre Drive O’Fallon, Missouri 63368 (636) 939-5100 http://www.synergeticsusa.com Attn: Pamela G. Boone, Chief Financial Officer
Synergetics USA, Inc.
CONTACT: Pamela G. Boone, Chief Financial Officer, Synergetics USA, Inc.,+1-636-939-5100
Web site: http://www.synergeticsusa.com/
